External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts
Open Access
- 1 December 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (11), 1434-1441
- https://doi.org/10.1038/bjc.1998.704
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for TherapyThrombosis and Haemostasis, 1997
- A Sensitive and Robust Assay for Urokinase and Tissue-Type Plasminogen Activators (Upa and Tpa) and Their Inhibitor Type I (Pai-1) in Breast Tumor CytosolsThe International Journal of Biological Markers, 1997
- Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 WorkshopEuropean Journal Of Cancer, 1996
- Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.1995
- Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1: Predictors of Poor Response to Tamoxifen Therapy in Recurrent Breast CancerJNCI Journal of the National Cancer Institute, 1995
- Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.Journal of Clinical Oncology, 1994
- Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasBritish Journal of Cancer, 1994
- High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.1993
- Biology and biochemistry of proteinases in tumor invasionPhysiological Reviews, 1993
- Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.1992